• Neoadjuvant therapy provides opportunity to discover new treatment strategies

    10 days ago - By Healio

    Editor's Note: In this guest commentary, Douglas Yee, MD, discusses results from several trials presented at this year's ASCO Annual Meeting that evaluated neoadjuvant therapy for breast cancer.
    Adjuvant breast cancer therapies historically have been performed as postsurgical treatment.
    Similarly, in clinical trials, adjuvant systemic therapy is applied after surgical removal of the tumor.
    Although advances have been made using this approach, it can take thousands of patients and years to determine if a new treatment strategy is superior to the standard of care. As molecular and
    Read more ...